altretamine has been researched along with Prostatic Neoplasms in 2 studies
Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Further phase I studies, with different PMM dosage schedules, are necessary before phase II studies can be recommended." | 1.27 | Hexamethylmelamine and pentamethylmelamine: an update. ( Hahn, DA, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hahn, DA | 1 |
| Drelichman, A | 1 |
| Brownlee, R | 1 |
| Al-Sarraf, M | 1 |
2 other studies available for altretamine and Prostatic Neoplasms
| Article | Year |
|---|---|
Hexamethylmelamine and pentamethylmelamine: an update.
Topics: Altretamine; Antineoplastic Agents; Drug Therapy, Combination; Female; Humans; Leukemia; Lung Neopla | 1983 |
Phase II study of hexamethylmelamine for disseminated prostatic carcinoma.
Topics: Aged; Altretamine; Drug Evaluation; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neopla | 1981 |